49 filings
8-K
NXGL
Nexgel Inc
1 Apr 24
Results of Operations and Financial Condition
8:41am
8-K
NXGL
Nexgel Inc
21 Feb 24
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
4:15pm
8-K
NXGL
Nexgel Inc
31 Jan 24
Regulation FD Disclosure
9:05am
8-K
NXGL
Nexgel Inc
16 Jan 24
Departure of Directors or Certain Officers
4:30pm
8-K
NXGL
Nexgel Inc
29 Dec 23
Entry into a Material Definitive Agreement
4:30pm
8-K
8i2ic1r6m5ovz
12 Dec 23
Departure of Directors or Certain Officers
4:52pm
8-K
gu4n9 hm855gtyfzc
11 Dec 23
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
8:15am
8-K
09hyp2w8
5 Dec 23
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line
8:10am
8-K
e6zaop7ut7 86vqa9
13 Nov 23
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
5:10pm
8-K
etszp5a4 anqq
30 Oct 23
NEXGEL Secures Supply Agreement with AbbVie
8:30am
8-K
9crl qal1vje6uo5x1
14 Aug 23
NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year
5:29pm
8-K
oqz2ef 8o
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
mhm 1bobfp2gz5v
6 Jun 23
Regulation FD Disclosure
8:30am
8-K
hkt2hls bbl1k1ndp1i
15 May 23
NEXGEL Reports First Quarter 2023 Financial Results
5:12pm
8-K
bb722
27 Mar 23
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
4:29pm
8-K
f7d71e1yx hbwe3rk
23 Mar 23
Other Events
4:30pm
8-K
tiadedunbxdxndw
2 Mar 23
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
9:00am
8-K
kahv jrdd
17 Jan 23
NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee
4:42pm
8-K
9ocwz2
6 Jan 23
Entry into a Material Definitive Agreement
4:15pm
8-K
itmq7b
7 Dec 22
NEXGEL Announces Share Repurchase Program
9:00am